Nectin-4 has emerged as a compelling target for breast cancer

被引:1
|
作者
Wang, Hui [1 ]
Sun, Dejuan [1 ]
Chen, Jinxia [1 ]
Li, Hua [1 ,2 ,3 ]
Chen, Lixia [1 ]
机构
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang 110016, Peoples R China
[2] Fujian Univ Tradit Chinese Med, Inst Struct Pharmacol, Coll Pharm, Fuzhou 350122, Peoples R China
[3] Fujian Univ Tradit Chinese Med, Coll Pharm, TCM Chem Biol, Fuzhou 350122, Peoples R China
基金
中国国家自然科学基金;
关键词
Nectin-4; Breast cancer; Biomarkers; Therapeutic strategies; TOLL-LIKE RECEPTORS; MEASLES-VIRUS; URSOLIC ACID; PROMISING CANDIDATE; ENFORTUMAB VEDOTIN; PROLACTIN RECEPTOR; SOLID TUMORS; T-CELLS; EXPRESSION; FUTURE;
D O I
10.1016/j.ejphar.2023.176129
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The incidence of breast cancer in women has increased year by year, becoming one of the most common malignant tumors in females worldwide. Most patients can be treated with surgery and endocrine drugs, but there are still some patients who lack effective treatment, such as triple-negative breast cancer (TNBC). Nectin-4, a protein encoded by poliovirus receptor-associated protein 4, is a Ca2+-independent immunoglobulin-like protein. It is mainly involved in the adhesion between cells. In recent years, studies have found that Nectin-4 is overexpressed in breast cancer and several other malignancies. Otherwise, several monoclonal antibodies and inhibitors targeting Nectin-4 have shown prosperous outcomes, so Nectin-4 has great potential to be a therapeutic target for breast cancer. The present review systematically describes the significance of Nectin-4 in each aspect of breast cancer, as well as the molecular mechanisms of these aspects mediated by Nectin-4. We further highlight ongoing or proposed therapeutic strategies for breast cancer specific to Nectin-4.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] NECTIN-4 targeted theranostics for urothelial cancer: getting ready for primetime?
    Filippi, Luca
    Schillaci, Orazio
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (1-2) : 1 - 4
  • [32] Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis
    Sethy, Chinmayee
    Goutam, Kunal
    Das, Biswajit
    Dash, Somya Ranjan
    Kundu, Chanakya Nath
    VASCULAR PHARMACOLOGY, 2021, 140
  • [33] Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer
    Zeindler, Jasmin
    Soysal, Savas Deniz
    Piscuoglio, Salvatore
    Ng, Charlotte K. Y.
    Mechera, Robert
    Isaak, Andrej
    Weber, Walter Paul
    Muenst, Simone
    Kurzeder, Christian
    FRONTIERS IN MEDICINE, 2019, 6
  • [34] Expression of Nectin-4 in Canine Mammary Carcinomas
    Dolu, H.
    Aydogan, A.
    ISRAEL JOURNAL OF VETERINARY MEDICINE, 2018, 73 (03): : 3 - 7
  • [35] Nectin-4 and Trop-2: new therapeutic targets in penile cancer?
    Mink, Jan
    Eckstein, Markus
    Khalmurzaev, Oybek
    Pryalukhin, Alexey
    Geppert, Carol
    Lohse, Stefan
    Bende, Kristof
    Lobo, Joao
    Henrique, Rui
    Loertzer, Hagen
    Steffens, Joachim
    Jeronimo, Carmen
    Wunderlich, Heiko
    Heinzelbecker, Julia
    Bohle, Rainer
    Stoeckle, Michael
    Matveev, Vsevolod
    Hartmann, Arndt
    Junker, Kerstin
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 239 - 239
  • [36] The soluble nectin-4 ecto-domain promotes breast cancer induced angiogenesis via endothelial Integrin-β4
    Siddharth, Sumit
    Nayak, Anmada
    Das, Sarita
    Nayak, Deepika
    Panda, Jyochanamayi
    Wyatt, Michael D.
    Kundu, Chanakya Nath
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 102 : 151 - 160
  • [37] High Expression of Nectin-4 in a Subset of Adnexal Carcinomas: A Potential Target for Enfortumab Vedotin Therapy
    Saade, Rayan
    Cho, Woo Cheal
    Nagarajan, Priya
    Aung, Phyu
    Marques-Piubelli, Mario
    Hudgens, Courtney
    Ledesma, Debora
    Nelson, Kelly
    Heberton, Meghan
    Ivan, Doina
    Zhang, Miao
    Torres-Cabala, Carlos
    Campbell, Matthew
    Prieto, Victor
    Wistuba, Ignacio
    Esmaeli, Bita
    Curry, Jonathan
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 354 - 356
  • [38] High Expression of Nectin-4 in a Subset of Adnexal Carcinomas: A Potential Target for Enfortumab Vedotin Therapy
    Saade, Rayan
    Cho, Woo Cheal
    Nagarajan, Priya
    Aung, Phyu
    Marques-Piubelli, Mario
    Hudgens, Courtney
    Ledesma, Debora
    Nelson, Kelly
    Heberton, Meghan
    Ivan, Doina
    Zhang, Miao
    Torres-Cabala, Carlos
    Campbell, Matthew
    Prieto, Victor
    Wistuba, Ignacio
    Esmaeli, Bita
    Curry, Jonathan
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 354 - 356
  • [39] The prognostic significance of Nectin-2 and Nectin-4 expression in glial tumors
    Dekanic, Andrea
    Babarovic, Emina
    Brlic, Paola Kucan
    Knezic, Matija
    Vukovic, Anita Savic
    Mazor, Marija
    Jonjic, Nives
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 244
  • [40] Harnessing multiple mechanisms of action to target Nectin-4 as anti-tumor therapeutics.
    Pei, Yi
    Pohl, Thomas
    Hassan, Ahmed
    Przybyla, Anna
    Yu, Raymond
    Lu, Huarui
    Tang, Fangqiang
    Chen, Kevin
    Jin, Wei
    Dominguez, Krizia
    Huang, Haichun
    Lei, Ming
    Liu, Zhong
    Li, Han
    CANCER RESEARCH, 2021, 81 (13)